N-(4-bromobutyl)-N-ethylmesitylenesulfonamide | 161452-15-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-bromobutyl)-N-ethylmesitylenesulfonamide
• 英文别名: N-ethyl-N-(4-bromobutyl)mesitylenesulfonamide；N-(4-bromobutyl)-N-ethyl-2,4,6-trimethylbenzenesulfonamide
• CAS: 161452-15-9
• 化学式: C₁₅H₂₄BrNO₂S
• 分子量: 362.331
• InChiKey: SDDJNOJHQZUPKW-UHFFFAOYSA-N

物化性质

• 沸点：
  449.7±55.0 °C(Predicted)
• 密度：
  1.280±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(4-bromobutyl)-N-ethylmesitylenesulfonamide 在 sodium hydride 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 20.0h， 生成 3,8,14-Tris(mesitylenesulfonyl)-3,8,14-Triazahexadecane
  参考文献：
  名称：

  A Comparison of Structure−Activity Relationships between Spermidine and Spermine Analogue Antineoplastics

  摘要：

  A systematic investigation of the impact of spermidine analogues both in vitro and in vivo is described. The study characterizes the effects of these analogues on L1210 cell growth, polyamine pools, ornithine decarboxylase, S-adenosyl-L-methionine decarboxylase, spermidine/spermine N-1-acetyltransferase, the maintenance of cellular charge, i.e., cationic equivalence associated with the polyamines and their analogues, and compares their ability to compete with spermidine for transport. The findings clearly demonstrate that the activity of-the linear polyamine analogues is highly dependent on the length of the triamines and the size of the N-alpha,N-omega-substituents. It appears that there is an optimum chain length for various activities and that the larger the N-alpha,N-omega-alkyls, the less active the compound. Metabolic transformation including N-dealkylation of these compounds is also evaluated. While there is no monotonic relationship between chain length and the ability of the analogue to be metabolized, the dipropyl triamines are clearly more actively catabolized than the corresponding methyl and ethyl systems. A comparison of the triamines with the corresponding tetraamines is made throughout the text regarding both in vitro activity against L1210 cells and in vivo toxicity measurements, suggesting that several triamine analogues may offer therapeutic advantages over the corresponding tetraamines.

  DOI：

  10.1021/jm960849j
• 作为产物：
  描述：

  1,4-二溴丁烷 、 N-ethylmesitylenesulfonamide 在 sodium hydride 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 0.5h， 以73%的产率得到N-(4-bromobutyl)-N-ethylmesitylenesulfonamide
  参考文献：
  名称：

  Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment

  摘要：

  聚胺具有以下结构式：或其与药学上可接受的酸盐，其中：R1-R6可能相同也可能不同，是烷基、芳基、芳基烷基、环烷基，可以选择性地由至少一个醚氧原子中断的烷基链，或氢；N1、N2、N3和N4是在生理pH下能够质子化的氮原子；a和b可能相同也可能不同，是从1到4的整数；A、B和C可能相同也可能不同，是有效维持氮原子之间距离的桥接基团，使聚胺：(i)在向人类或非人类动物施用后能够被目标细胞吸收；(ii)在被目标细胞吸收后，通过正电荷氮原子之间的静电相互作用与目标细胞内的天然聚胺基本相同的生物对应阴离子竞争结合；聚胺，在细胞中与生物对应阴离子结合后，在生物学上与细胞内聚胺以不同方式发挥作用，这种聚胺在自然界中不存在；以及包含聚胺的药物组合物和治疗需要抗肿瘤治疗的患者的方法。

  公开号：

  US06342534B1

文献信息

• Methods and compositions for the treatment of neurodegeneration
  申请人：University Of Florida Research Foundation, Inc.

  公开号：US05886051A1

  公开（公告）日：1999-03-23

  Methods and pharmaceutical compositions in unit dosage form for treating neurodegeneration in a human or non-human animal afflicted therewith wherein the active agent is a therapeutically effective amount of a polyamine having the formula: ##STR1## or a salt thereof with a pharmaceutically acceptable acid wherein: R.sub.1 and R.sub.6 may be the same or different and are hydrogen, alkyl, hydrocarbyl aryl, hydrocarbyl aryl alkyl, cycloalkyl, or any of the foregoing wherein the alkyl chain is interrupted by at least one etheric oxygen atom; N.sup.1, N.sup.2, N.sup.3 and N.sup.4 are nitrogen atoms capable of protonation at physiological pH's; a and b may be the same or different and are integers from 1 to 4; A, B and C may be the same or different and are bridging groups of variable length.

  用于治疗人类或非人类动物神经退行性疾病的单剂量形式的方法和药物组合物，其中活性药物是具有以下结构的聚胺的治疗有效量或其与药用酸的盐：R.sub.1和R.sub.6可以相同也可以不同，是氢、烷基、烃基芳基、烃基芳基烷基、环烷基或前述任何其中烷基链被至少一个醚氧原子打断的物质；N.sup.1、N.sup.2、N.sup.3和N.sup.4是在生理pH下能够质子化的氮原子；a和b可以相同也可以不同，是从1到4的整数；A、B和C可以相同也可以不同，是可变长度的桥联基。
• [EN] NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES<br/>[FR] NOUVEAUX CONJUGUES D'ANALOGUE DE POLYAMINE ET CONJUGUES DE QUINONE, UTILISES POUR LE TRAITEMENT DE CANCERS ET DE MALADIES DE LA PROSTATE
  申请人：SLIL BIOMEDICAL CORP

  公开号：WO2000066175A2

  公开（公告）日：2000-11-09

  Peptide conjugates in which cytocidal and cytostatic agents, such as polyamine analogs or naphthoquinones, are conjugated to a polypeptide recognized and cleaved by enzymes such as prostate-specific antigen (PSA) and cathepsin B are provided, as well as compositions comprising these conjugates. Methods of using these conjugates in the treatment of prostate diseases are also provided.

  提供一种肽共轭物，其中将细胞毒性和细胞增殖抑制剂，如多胺类似物或萘醌类化合物，与多肽共轭，该多肽可以被酶如前列腺特异性抗原（PSA）和半胱氨酸蛋白酶B识别和剪切，以及包含这些共轭物的组合物。还提供了使用这些共轭物治疗前列腺疾病的方法。
• Biologically active spermidine analogues, pharmaceutical compositions and methods of treatment
  申请人：——

  公开号：US20020045780A1

  公开（公告）日：2002-04-18

  Polyamines having the formula: 1 or a salt thereof with a pharmaceutically acceptable acid wherein: R 1 -R 5 may be the same or different and are alkyl, aryl, aryl alkyl, cycloalkyl or hydrogen; at least one of R 1 and R 2 and at least one of R 4 and R 5 are not hydrogen, and any of the alkyl chains may optionally be interrupted by at least one etheric oxygen atom, excluding N 1 ,N 3 -diethylspermidine and N 1 ,N 3 -dipropylspermidine; and A and B are bridging groups which effectively maintain the distance between the nitrogen atoms such that the polyamine: (i) is capable of uptake by a target cell upon administration of the polyamine to a human or non-human animal; and (ii) upon uptake by the target cell, competitively binds via an electrostatic interaction between the positively charged nitrogen atoms to substantially the same biological counter-anions as the intracellular natural polyamines in the target cell.

  具有以下公式1或其药学上可接受的酸盐的多胺，其中：R1-R5可以相同或不同，且为烷基，芳基，芳基烷基，环烷基或氢；R1和R2中至少有一个，以及R4和R5中至少有一个不是氢，任何烷基链都可以选择性地被至少一个醚氧原子中断，但不包括N1，N3-二乙基亚精胺和N1，N3-二丙基亚精胺；A和B是桥接基团，有效地保持氮原子之间的距离，使得多胺：（i）在将多胺用于人类或非人类动物的治疗时，能够被目标细胞吸收；（ii）在被目标细胞吸收后，通过正电荷氮原子之间的静电相互作用与目标细胞中的细胞内天然多胺基本相同地竞争性结合生物计数离子。
• Antiproliferative Properties of Polyamine Analogs: A Structure-Activity Study
  作者：Raymond J. Bergeron、James S. McManis、Charles Z. Liu、Yang Feng、William R. Weimar、Gabriel R. Luchetta、Qianhong Wu、Jackqueline Ortiz-Ocasio、J. R. Timothy Vinson

  DOI：10.1021/jm00047a004

  日期：1994.10

  A basis set of polyamine analogues was designed and synthesized. These compounds were used to initiate a systematic investigation of the role of chain length, terminal nitrogen alkyl group size, and symmetry of the methylene backbone in the antineoplastic properties of polyamine analogues. New synthetic methods predicated on our earlier polyamine fragment synthesis are described for accessing the tetraamines of interest. An unsymmetrically substituted diamine reagent, N-(tert-butoxycarbonyl)-N,N'-bis(mesitylene sulfonyl)-1,4- di-aminobutane, was developed for entry into unsymmetrical tetraamines. All of the tetraamines synthesized were first evaluated in a murine leukemia L1210 cell IC50 assay at 48 and 96 h. In an attempt to correlate this behavior with some aspect of polyamine metabolism, each compound was tested for its ability to compete with spermidine for the polyamine uptake apparatus, its impact on the polyamine biosynthetic enzymes ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (AdoMetDC), and its effect on the polyamine-catabolizing enzyme spermidine/spermine N-1-acetyltransferase (SSAT) and on polyamine pools. While there was no obvious correlation between the 48 and 96 h IC50'S and the impact of the analogues on polyamine metabolism, there were other structure-activity relationships. Correlations were observed to exist between chain length and IC50'S and between terminal alkyl substituents and impact on K-i, ODC, and AdoMetDC. Also, preliminary studies suggest a relationship may exist between the 48 and 96 h IC50's activities and the analogue's chronic toxicity in vivo. Finally, when the overall length of the polyamine backbone was held constant, the symmetry of the methylene chains of the polyamine fragments was shown to be unimportant to the compound's activity.
• US6184232
  申请人：——

  公开号：——

  公开（公告）日：——